Company intelligence / Profile preview

Shimadzu Corporation

Ownership: Private
Employees: ~10395
Development stage: Other

Overview

Shimadzu’s clinical diagnostic platforms (e.g. mass spectrometry, TOF-PET, and X-ray imaging) are established and used globally, with continuing innovation including world-first diagnostic and imaging systems

Modalities: DeviceDiagnostic platform
Industry: Medical Imaging

Partnerships

Partnerships with hospitals, clinical labs, academic institutions, and pharmaceutical companies for instrument installation and validation (specifics rarely publicized)

Beyond the preview

Go deeper on Shimadzu Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shimadzu Corporation.